DiaSorin Molecular LLC announces the availability of three new primer pairs, or Analyte Specific Reagents (ASRs), which can be used in laboratory-developed tests (LDTs).
Cypress, Calif. (December 21, 2018) –DiaSorin Molecular LLC announces the availability of three new primer pairs, or Analyte Specific Reagents (ASRs), which can be used in laboratory-developed tests (LDTs). The specific targets are Legionella species, Chlamydophila pneumoniae and Mycoplasma pneumoniae, all of which may infect the lungs.
Legionella, which causes Legionnaire’s Disease, is the most serious of the three, and about one in ten people who get sick with it will die due to complications. There are an estimated 300,000 cases of C. pneumoniae each year in the U.S., with a range of severity. M. pneumoniae often causes “walking pneumonia,” although it can progress to full pneumonia. Both C. pneumoniae and M. pneumoniae are spread by human contact, whereas Legionella is spread by breathing droplets of contaminated water.
“Molecular tests that make use of primer pairs, such as the new ASRs, may be useful in detecting these bacteria that are difficult to culture,” said Michelle Tabb, chief scientific officer for DiaSorin Molecular. “We are a leader in the development and manufacture of ASRs, with a growing menu of more than 55 primer pairs.”
About DiaSorin Molecular
DiaSorin Molecular LLC manufactures and distributes innovative molecular diagnostic products for hospital and reference laboratories. The company’s products help laboratories consolidate their testing, streamline processes and increase efficiency. DiaSorin Molecular’s Simplexa® molecular diagnostic kits are designed for use on the company’s versatile LIAISON® MDX platform. The company provides service and support solutions for its kits and instruments through a global network of offices and distributors. DiaSorin Molecular also markets a range of ASRs (Analyte Specific Reagents) for use in laboratory-developed tests.
